Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Imaging Substudy in Knee Osteoarthritis (IM-LOSEIT-II)
NCT02928679Phase 4Completed
- Start
- Nov 2016
- Primary completion
- Feb 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoarthritis (OA) and obesity comparing Liraglutide 3 mg with Placebo (2 arms). Primary endpoint: Change in the degree of inflammation in the knee-joint (DCE-MRI). Started Nov 2016; status: completed.
02
Drugs
03
Conditions
osteoarthritis (OA)obesity
Beyond the preview
Go deeper on NCT02928679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02928679.